S100A4 and carcinoma: The levels of p-STAT3 and S100A4 were significantly decreased in RP11-54O7.17 overexpressed cells, whereas carcinoma cell viability and S100A4 expression were dose-dependently reduced after transcription of different concentrations of RP11-54O7.17 in vitro.